{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-127253","form_type":"8-K","ticker":"MREO","cik":"0001719714","company_name":"Mereo BioPharma Group plc","filed_at":"2026-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.996757+00:00","generated_at":"2026-05-15T08:39:54.488585+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Dr. Annalisa Jenkins not seeking re-election to Mereo BioPharma board","bullets":["Dr. Annalisa Jenkins will not stand for re-election at the 2026 AGM scheduled for May 14, 2026.","Her decision did not result from any disagreement with the Company or Board on operations, policies, or practices.","She will continue to serve as a director until her term expires immediately prior to the 2026 AGM."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-127253","json":"https://secwatch.observer/filing/0001193125-26-127253.json","markdown":"https://secwatch.observer/filing/0001193125-26-127253.md","text":"https://secwatch.observer/filing/0001193125-26-127253.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719714/000119312526127253/0001193125-26-127253-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719714/000119312526127253/mreo-20260326.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:39:54.488585+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}